文献速递重症综合管理与镇静镇痛复苏、休克与脓毒症

普伐他汀预处理与高碳酸血症对脓毒症肠道微血管氧合及血流的影响

Effect of Pravastatin Pretreatment and Hypercapnia on Intestinal Microvascular Oxygenation and Blood Flow During Sepsis.
PubMed 文献 · Shock · 2020-01-01
一句话结论动物实验显示普伐他汀预处理可防止脓毒症肠道微血管氧合下降,但合并中度急性高碳酸血症时该效应消失。

该研究将40只雄性Wistar大鼠随机分为四组,半数接受普伐他汀0.2 mg·kg皮下注射,半数接受等体积生理盐水对照,18小时后行结肠升段支架腹膜炎手术诱导脓毒症,术后24小时基线评估后分别接受120分钟常碳酸血症(pCO2 40±6 mmHg)或中度高碳酸血症(pCO2 72±10 mmHg)通气。结果显示常碳酸血症脓毒症动物微血管氧合随时间下降(-8.4±8.7%,P<0.05 vs 基线),而普伐他汀预处理组保持稳定(-1.9±5.7% vs 基线);但在高碳酸血症条件下,普伐他汀预处理组微血管氧合显著下降(-8.9±11.8%,P<0.05 vs 基线),且显著低于常碳酸血症普伐他汀预处理组。各组微血流随时间均无变化。作者认为普伐他汀预处理改善脓毒症肠道微血管氧合,而额外高碳酸血症可消除该效应,提示脓毒症ARDS患者可能无法从他汀治疗中获益。

要点

  • 常碳酸血症脓毒症大鼠中,普伐他汀预处理组肠道微血管氧合保持稳定(-1.9±5.7% vs 基线),而对照组下降(-8.4±8.7%,P<0.05 vs 基线)。
  • 高碳酸血症(pCO2 72±10 mmHg)脓毒症大鼠中,普伐他汀预处理组微血管氧合显著下降(-8.9±11.8%,P<0.05 vs 基线),且显著低于常碳酸血症普伐他汀组。
  • 各组肠道微血流随时间均无变化,提示氧合变化并非由血流改变介导。
  • 作者认为普伐他汀预处理似乎可预防脓毒症肠道缺氧,但合并高碳酸血症时该效应被消除。

适用人群与场景

  • 实验性脓毒症雄性Wistar大鼠,行结肠升段支架腹膜炎手术诱导脓毒症。

处置流程与药物剂量

  • 普伐他汀0.2 mg·kg皮下注射预处理,18小时后行结肠升段支架腹膜炎手术,术后24小时进行120分钟常碳酸血症(pCO2 40±6 mmHg)或中度高碳酸血症(pCO2 72±10 mmHg)通气。

研究设计与关键结果

  • 研究类型:动物实验,40只雄性Wistar大鼠随机分为四组。
  • 干预与对照:半数动物接受普伐他汀0.2 mg·kg皮下注射,半数接受等体积生理盐水(NaCl 0.9%)对照;所有动物行结肠升段支架腹膜炎手术诱导脓毒症,术后24小时接受120分钟常碳酸血症或中度高碳酸血症通气。
  • 主要终点:常碳酸血症脓毒症动物微血管氧合随时间下降(-8.4±8.7%,P<0.05 vs 基线),普伐他汀预处理组保持稳定(-1.9±5.7% vs 基线);高碳酸血症脓毒症普伐他汀预处理组微血管氧合显著下降(-8.9±11.8%,P<0.05 vs 基线),且显著低于常碳酸血症普伐他汀预处理组。
  • 次要终点:各组微血流随时间均无变化。

证据类型、等级与局限

  • 证据类型:动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为普伐他汀预处理改善脓毒症肠道微血管氧合,似乎可预防肠道缺氧;额外高碳酸血症可消除该效应,提示脓毒症ARDS患者可能无法从他汀治疗中获益。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

INTRODUCTION: In septic patients, adequate microvascular oxygenation (μHBO2) of the intestine is vital for their outcome. Recent studies suggest that statins can ameliorate septic microcirculation in a variety of tissues. However, the effect on intestinal microvascular oxygenation and blood flow is largely unknown. Furthermore, there are indications that statin therapy might not be beneficial in the presence of hypercapnia, as observed in septic acute respiratory distress syndrome (ARDS) patients. Therefore, the present study explores the effect of pravastatin with and without additional moderate acute hypercapnia on intestinal microvascular oxygenation and blood flow in experimental sepsis.

METHODS: Forty male Wistar rats were randomized into four groups. Half of the animals received 0.2 mg • kg pravastatin s.c., the other half received the same volume as vehicle (NaCl 0.9%). After 18 h, colon ascendens stent peritonitis surgery was conducted in all animals to induce sepsis. Twenty-four hours after surgery, baseline was established and the animals were subjected to either 120 min of normocapnic (pCO2 40 ± 6 mm Hg) or moderate hypercapnic (pCO2 72 ± 10 mm Hg) ventilation. Microcirculatory oxygenation (μHBO2) and perfusion (μflow) of the colon were continuously recorded using tissue reflectance spectrophotometry and laser Doppler, respectively.

RESULTS: In normocapnic septic animals μHBO2 decreased over time (-8.4 ± 8.7%; P < 0.05 vs. baseline), whereas after pravastatin pretreatment μHBO2 remained constant (-1.9 ± 5.7% vs. baseline). However, in hypercapnic septic animals pretreated with pravastatin μHBO2 declined significantly over time (-8.9 ± 11.8%; P < 0.05 vs. baseline) and was significantly lower compared with normocapnic pravastatin-pretreated animals. μflow did not change over time in any group.

CONCLUSION: Pravastatin pretreatment ameliorates the intestinal microvascular oxygenation in sepsis and thus seems to prevent intestinal hypoxia. Furthermore, we demonstrated that additional hypercapnia abolishes this effect, indicating why septic ARDS patients might not benefit from pravastatin therapy.

来源:Shock,查看原文。版权归原作者所有。

参考来源

  1. Schulz J, Vollmer C, Truse R, et al. Effect of Pravastatin Pretreatment and Hypercapnia on Intestinal Microvascular Oxygenation and Blood Flow During Sepsis. Shock. 2020. PMID: 30724816. doi:10.1097/SHK.0000000000001323

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。